JAMA Network Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-10-08 ms3000001554426653 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：RCT
经验分享：审稿第33天了还要多久呀挺着急的

77 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-12-09 ms2000001856106684 来自北京

偏重的研究方向：公共卫生;运动营养
经验分享：Submission Pending 11-28-2024 02:34
In Quality Control 11-28-2024 04:23
Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编
agree to consider your manuscript
截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。

36 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-10-22 ms4000000172220770 来自湖南省

Under Review 10-21-2024
In Quality Control 10-21-2024

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-10-22 xuyihan 来自江苏省

5天了没动
Under Review 10-17-2024
In Quality Control 10-17-2024

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-11-19 ms5000001176841326 来自宁夏

偏重的研究方向：公共卫生
经验分享：Submission Pending 11-14-2024
In Quality Control 11-14-2024
Under Review 11-14-2024
Review Complete - Decision Processed 11-18-2024

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2023-12-03 ms8000001562779487 来自广东省

想問一下GBD數據庫的文章收不收的?

140 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2022-04-21 summer月

审稿速度:2.0
经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了
2022/02/28 Submission pending
2021/01/28 In Quality Control
2021/01/28 Under Review
2021/03/24 Review Complete - Decision Processed reject

1375 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2023-05-19 doctor0805 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;开放获取
经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！

566 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-11-18 ms9000001085107463 来自贵州省

偏重的研究方向：公共卫生
经验分享：记录一下
In Quality Control 11-03-2024
Under Review 11-14-2024
Review Complete - Decision Processed 11-15-2024

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229715, encodeId=63aa2229e1597, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：RCT 经验分享：审稿第33天了还要多久呀挺着急的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2518331004, createdName=ms3000001554426653, createdTime=Tue Oct 08 08:39:32 CST 2024, time=2024-10-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241522, encodeId=098a22415222f, content=偏重的研究方向：公共卫生;运动营养 经验分享：Submission Pending 11-28-2024 02:34 In Quality Control 11-28-2024 04:23 Under Review 12-02-2024 12:50 Your manuscript has been assigned the following manuscript number，主编 agree to consider your manuscript 截止到12.09 12:00 ，Reviewing Editor处还是NA；请问各路大神都多久会在系统中明确Reviewing Editor呢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c725394741, createdName=ms2000001856106684, createdTime=Mon Dec 09 12:03:47 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232378, encodeId=e96222323e8e3, content=Under Review 10-21-2024 In Quality Control 10-21-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38a9499102, createdName=ms4000000172220770, createdTime=Tue Oct 22 11:15:47 CST 2024, time=2024-10-22, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2232506, encodeId=fb432232506e3, content=5天了没动 Under Review 10-17-2024 In Quality Control 10-17-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbkwiamQRUZ02EtNQ6eQflk4CHafHibKTV9ju5ia6AkEvQuZagYnTGsFTuibpHDwZUicuFmVBsIZ0qbJg/0, createdBy=bc812071404, createdName=xuyihan, createdTime=Tue Oct 22 16:25:46 CST 2024, time=2024-10-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2237721, encodeId=1b0d223e72151, content=偏重的研究方向：公共卫生 经验分享：Submission Pending 11-14-2024 In Quality Control 11-14-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-18-2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5779540416, createdName=ms5000001176841326, createdTime=Tue Nov 19 01:03:46 CST 2024, time=2024-11-19, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2172721, encodeId=b5cb21e272146, content=想問一下GBD數據庫的文章收不收的?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Sun Dec 03 18:57:51 CST 2023, time=2023-12-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1375, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看万博manbetx登录里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=566, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海)]

2024-05-26 ms4000001705401903 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心理健康;公共卫生
经验分享：从 JAMA Psychiatry转投
Manuscript Transferred 12-14-2023
Submission Pending 12-14-2023
In Quality Control 12-14-2023
Under Review 12-15-2023
Review Complete - Decision Processed 12-18-2023
（编辑表示对稿件感兴趣，但需要语言修改后才能送外审）

语言检查修改后重新提交
Submission Pending 12-27-2023
In Quality Control 12-27-2023
Under Review 12-27-2023
Review Complete - Decision Processed 04-01-2024
（经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改）

（修改了整整三周，重新提交）
Submission Pending 04-20-2024
In Quality Control 04-20-2024
Under Review 04-20-2024
Review Complete - Decision Processed 05-15-2024
（25天后，接收）

324 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务